Unity Health Toronto
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.unityhealth.to
Phage Therapy for the Treatment of Urinary Tract Infection
Phase 1
Active, not recruiting
- Conditions
- Recurrent Urinary Tract Infection
- Interventions
- Biological: Phage Therapy
- First Posted Date
- 2022-09-13
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 1
- Registration Number
- NCT05537519
- Locations
- 🇨🇦
St. Joseph's Health Centre, Toronto, Ontario, Canada
SMILE Trial - Imaging Sub-Study
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Nitrous oxide gas for inhalationDrug: Midazolam injection
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 11
- Registration Number
- NCT05528718
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy
Phase 2
Recruiting
- Conditions
- Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
- Interventions
- Drug: Intravitreal topotecanProcedure: Pars plana vitrectomy with or without scleral buckle
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 50
- Registration Number
- NCT05523869
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦St. Michael's Hospital, Toronto, Ontario, Canada
Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness
Not Applicable
Terminated
- Conditions
- COVID-19 PneumoniaComplicationDeathHospitalizationCOVID-19ProningOutpatient
- Interventions
- Other: Self-proning
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 11
- Registration Number
- NCT05518474
- Locations
- 🇨🇦
St. Joseph's Health Centre, Toronto, Ontario, Canada
Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.
Not Applicable
Recruiting
- Conditions
- Blood-Borne InfectionsHarm ReductionHIV Self-testingHIVSexually Transmitted Diseases
- Interventions
- Other: Our Healthbox (smart vending machine or interactive dispensing system)
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 5000
- Registration Number
- NCT05516069
- Locations
- 🇨🇦
Ensemble, Moncton, New Brunswick, Canada
Auditory MMN EEG in TRD in Response to Ketamine
Recruiting
- Conditions
- Treatment-resistant Depression (TRD)
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT05464264
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
A PILOT Study on LSGB vs EMB in the Diagnosis of Cardiac Transthyretin Amyloidosis
- Conditions
- Amyloidosis
- Interventions
- Procedure: Lip Salivary Gland Biopsy
- First Posted Date
- 2022-05-16
- Last Posted Date
- 2022-05-23
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 20
- Registration Number
- NCT05375279
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
Temporal Interference and Depression
Not Applicable
Not yet recruiting
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Sham stimulationDevice: Temporal Interference stimulation
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT05295888
Cryoneurolysis for TKA - a Pilot Study
Not Applicable
Recruiting
- Conditions
- Knee Pain ChronicOsteoarthritis
- Interventions
- Device: Iovera - CryoneurolysisDrug: Local anesthetic
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 20
- Registration Number
- NCT05286996
- Locations
- 🇨🇦
St Michael's Hospital, Toronto, Ontario, Canada
Sirolimus for Nosebleeds in HHT
Phase 2
Active, not recruiting
- Conditions
- NosebleedsEpistaxisHereditary Hemorrhagic Telangiectasia
- Interventions
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 10
- Registration Number
- NCT05269849
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath